96 / 164
226
subcutaneous insulin infusion versus multiple daily injections
of insulin: economic comparison in adult and adolescent
type 1 diabetes mellitus in Australia. Pharmacoeconomics.
2007;25:881-897.
29. Cummins E, Royle P, Snaith A, et al. Clinical effectiveness and
costeffectiveness of continuous subcutaneous insulin infusion
for diabetes: systematic review and economic evaluation.
Health Technol Assess 2010;14:iii-iv, xi-xvi, 1-181.
30. Norgaard K, Sohlberg A, Goodall G. Cost-effectiveness of
continuous subcutaneous insulin infusion therapy for type 1
diabetes. Ugeskr Laeger. 2010; 172:2020-2025.
31. Gómez A, Marín A. Monitorización continua de glucosa en
tiempo real: imprescindible su uso combinado con infusión
continua de insulina. Av Diabetol. 2011;27:143-150.
32. Bailey T, Bode B, Christiansen M, et al. The Performance and
Usability of a Factory-Calibrated Flash Glucose Monitoring
System. Diabetes Technol Ther 2015; 17: 787-794.
33. Keenan D, Mastrototaro J, Zisser H, et al. Accuracy of the Enlite
6-Day Glucose Sensor with Guardian and Veo Calibration
Algorithms. Diabetes Technol Ther. 2012 Mar;14:225-231.
34. Heinemann L, De Vries H. Evidence for continuous glucose
monitoring: sufficient for reimbursement?. Diabet Med 2014;
31: 122–125.
35. Tumminia A, Sciacca L, Frittitta L, et al. Integrated insulin
pump therapy with continuous glucose monitoring for
improved adherence: technology update. Patient Prefer
Adherence 2015; 9:1263-1270.
36. Hirsh I, Abelseth J, Bode B, et al. Sensor-Augmented Insulin
Pump Therapy: Results of the First Randomized Treat-to-
Target Study. Diabetes Technol Ther. 2008; 10:377-383.
37. Tamborlane W, Beck R, Bode B, et al. Continuous Glucose
Monitoring and Intensive Treatment of Type 1 Diabetes The
Juvenile Diabetes Research Foundation Continuous Glucose
Monitoring Study Group. N Engl J Med 2008;359:1464-
1476.
38. Raccah D, Sulmont V, Reznik Y, et al. Incremental Value of
Continuous Glucose Monitoring When Starting Pump Therapy
in Patients With Poorly Controlled Type 1 Diabetes The
RealTrend study. Diabetes Care 2009; 32:2245–2250.
39. Bergenstal R, Tamborlane W, Ahmann A, et al. Effectiveness of
Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes.
N Engl J Med. 2010; 363:311-320.
40. Kordonouri O, Pankowska E, Rami B, et al. Sensor-augmented
pump therapy from the diagnosis of childhood type 1 diabetes:
results of the Paediatric Onset Study (ONSET) after 12 months
of treatment. Diabetologia 2010; 53: 2487–2495.
41. Choudhary P, Rickles M, Senior P, et al. Evidence-Informed
Clinical Practice Recommendations for Treatment of Type
1 Diabetes Complicated by Problematic Hypoglycemia.
Diabetes Care 2015;38:1016–1029.
42. International Hypoglycaemia Study Group. Minimizing
Hypoglycemia in Diabetes. Diabetes Care. 2015; 38:1583-
1591.
[REV. MED. CLIN. CONDES - 2016; 27(2) 213-226]